Syphilis and human immunodeficiency virus (HIV)-1 coinfection: Influence on CD4 T-cell count, HIV-1 viral load, and treatment response

Sexually Transmitted Diseases

Volumn 33, Issue 3, 2006, Pages 143-148

  Kofoed, Kristian ^a   Gerstoft, Jan ^b   Mathiesen, Lars R ^a   Benfield, Thomas ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BENZATHINE PENICILLIN; DOXYCYCLINE; PENICILLIN G; PROCAINE PENICILLIN; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE; REAGINIC ANTIBODY;

ADULT; ARM WEAKNESS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; NEUROSYPHILIS; REAGIN TEST; SEROLOGY; STATISTICAL SIGNIFICANCE; SUPERINFECTION; SYPHILIS; TREATMENT FAILURE; VIRUS LOAD; BLOOD; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DENMARK; DOXYCYCLINE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PENICILLINS; REAGINS; RNA, VIRAL; SYPHILIS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33646015696     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000187262.56820.c0     Document Type: Article

References (38)

1. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 2004; 80:255-263.
2. Hopkins S, Lyons F, Coleman C, et al. Resurgence in infectious syphilis in Ireland: an epidemiological study. Sex Transm Dis 2004; 31:317-321.
3. Halsos AM, Edgardh K. An outbreak of syphilis in Oslo. Int J STD AIDS 2002; 13:370-372.
4. Cowan S. Syphilis in Denmark: outbreak among MSM in Copenhagen, 2003-2004. Euro Surveill 2004; 12:17-18.
5. Centers for Disease Control and Prevention. Trends in primary and secondary syphilis and HIV infections in men who have sex with men: San Francisco and Los Angeles, California, 1998-2002. MMWR Morb Mortal Wkly Rep 2004; 53:575-578.
6. Hourihan M, Wheeler H, Houghton R, et al. Lessons from the syphilis outbreak in homosexual men in east London. Sex Transm Infect 2004; 80:509-511.
7. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28:579-597.
8. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259:1048-1050.
9. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
10. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18:2075-2079.
11. Donovan RM, Bush CE, Markowitz NP, et al. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996; 174:401-403.
12. Bush CE, Donovan RM, Markowitz NP, et al. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immun Defic Syndr Hum Retrovirol 1996; 13:23-26.
13. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1: Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
14. Baeten JM, Overbaugh J. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 2003; 1:69-86.
15. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998; 177:224-227.
16. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1: AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-1873.
17. Paz-Bailey G, Meyers A, Blank S, et al. A case-control study of syphilis among men who have sex with men in New York City: association with HIV infection. Sex Transm Dis 2004; 31:581-587.
18. Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep 2003; 5:145-152.
19. Ven PV, Mao L, Fogarty A, et al. Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS 2005; 19:179-184.
20. Dornadula G, Zhang H, VanUitert B, et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 1999; 282:1627-1632.
21. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002; 420:434-439.
22. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
23. Martinez-Picado J, DePasquale MP, Kartsonis N, et al. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A 2000; 97:10948-10953.
24. Pope V, Larsen SA, Rice RJ, et al. Flow cytometric analysis of peripheral blood lymphocyte immunophenotypes in persons infected with Treponema pallidum. Clin Diagn Lab Immunol 1994; 1:121-124.
25. Cohen Stuart JW, Wensing AM, Kovacs C, et al. Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance. J Acquir Immun Defic Syndr 2001; 28:105-113.
26. Gunthard HF, Frost SD, Leigh-Brown AJ, et al. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol 1999; 73:9404-9412.
27. Havlir DV, Bassett R, Levitan D, et al. Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA 2001; 286:171-179.
28. Karlsson AC, Younger SR, Martin JN, et al. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS 2004; 18:981-989.
29. Hermankova M, Ray SC, Ruff C, et al. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA 2001; 286:196-207.
30. Nettles RE, Kieffer TL, Kwon P, et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA 2005; 293:817-829.
31. Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003; 17:1907-1915.
32. Smith CJ, Sabin CA, Lampe FC, et al. The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy. AIDS 2003; 17:963-969.
33. Krakauer T, Buckley M. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Anti-microb Agents Chemother 2003; 47:3630-3633.
34. Padte N, Rowe L, Hurley A, et al. Sustained viremia during highly active antiretroviral therapy with accelerated proviral DNA decay in the setting of infection with syphilis. AIDS 2003; 17:2143-2145.
35. Zink MC, Uhrlaub J, DeWitt J, et al. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005; 293:2003-2011.
36. Berry CD, Hooton TM, Collier AC, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316:1587-1589.
37. Zenilman JM, Rand S, Barditch P, et al. Asymptomatic neurosyphilis after doxycycline therapy for early latent syphilis. Sex Transm Dis 1993; 20:346-347.
38. Goorney B, Leahy M. Relapse of early syphilis on first line treatment. Int J STD AIDS 2002; 13:722-723.